Good article on Bloomberg today around big pharma/biotech buyouts and takeovers;
https://www.bloomberg.com/opinion/articles/2019-12-16/amarin-fish-oil-heart-drug-good-news-is-already-priced-in-stock?srnd=premium-asia
Relates to a bio-pharmaceutical company (Amarin) that's managed to patent a fish oil supplement (Vascepa) in pill form as a heart attack and stroke preventative.
Interesting points around restricted FDA approval, and a comment that insurance reimbursal wasn't assured, despite the low cost, because of the numbers of people likely to be taking it.
Good article on Bloomberg today around big pharma/biotech...
-
- There are more pages in this discussion • 3,790 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.035(13.7%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 29.0¢ | 25.0¢ | $162.3K | 595.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49897 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 24504 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |